e-learning
resources
Vienna 2009
Sunday, 13.09.2009
Pulmonary arterial hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Sympathetic nervous system activation is an independent prognostic factor of clinical deterioration in pulmonary arterial hypertensive patients
A. Ciarka, V. Phoung, S. Huez, J. L. Vachiery, R. Naeije, P. van de Borne (Brussels, Belgium)
Source:
Annual Congress 2009 - Pulmonary arterial hypertension
Session:
Pulmonary arterial hypertension
Session type:
E-Communication Session
Number:
1484
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Ciarka, V. Phoung, S. Huez, J. L. Vachiery, R. Naeije, P. van de Borne (Brussels, Belgium). Sympathetic nervous system activation is an independent prognostic factor of clinical deterioration in pulmonary arterial hypertensive patients. Eur Respir J 2009; 34: Suppl. 53, 1484
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
Clinical relevance of autonomic nervous system disturbances in pulmonary arterial hypertension
Source: Eur Respir J 2009; 34: 792-794
Year: 2009
Clinical relevance of autonomic nervous system disturbances in pulmonary arterial hypertension
Source: Eur Respir J 2010; 35: 704-705
Year: 2010
Analysis of the cardiac index-PvO2 relationship during vasodilatation challenge as a prognostic factor in pulmonary arterial hypertension
Source: Annual Congress 2011 - Physiology of human pulmonary hypertension
Year: 2011
Sympathetic nervous stress during exercise is a good prognostic predictor in patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 540s
Year: 2003
Increased renin-angiotensin-aldosteron system activity in lungs of patients with idiopathic pulmonary arterial hypertension
Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension
Year: 2011
Impaired cardiac autonomic control relates to disease severity in pulmonary hypertension
Source: Eur Respir J 2009; 34: 895-901
Year: 2009
Renin-angiotensin-aldosterone system activation in different vasculature areas in primary pulmonary hypertension
Source: Eur Respir J 2004; 24: Suppl. 48, 1s
Year: 2004
Renal dysfunction correlates with impaired hemodynamics and unfavorable outcome in pulmonary arterial hypertension
Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects
Year: 2010
Towards prognostic biomarkers in pulmonary arterial hypertension
Source: Eur Respir J 2012; 39: 799-801
Year: 2012
The effect of long-term specific therapy on clinical outcome, echocardiographic and sympatho-vagal balance as assessed by heart rate variability in pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary vascular diseases
Year: 2009
Determinants and prognostic value of kidney disease in pulmonary arterial hypertension
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018
Pulmonary vascular response to exercise in heart-failure patients with pulmonary hypertension: role of a pre-capillary component
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017
Survival and prognostic factors of acute exacerbations of pulmonary arterial hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 342s
Year: 2007
Pulmonary arterial hypertension associated with sarcoidosis (BBS-PAH): mechanisms, hemodynamics and prognosis
Source: Eur Respir J 2002; 20: Suppl. 38, 371s
Year: 2002
Correlation between sympathovagal modulation and functional capacity in pulmonary arterial hypertension patients.
Source: International Congress 2018 – Pulmonary hypertension: right ventricle function, haemodynamics and exercise
Year: 2018
The association of cardiovascular autonomic dysfunction and the prediction of COPD can be explained by neurohumoral activation
Source: Eur Respir J, 51 (6) 1800737; 10.1183/13993003.00737-2018
Year: 2018
Altered control of cerebral circulation in chronic obstructive pulmonary disease: an early sign of cardiovascular autonomic dysfunction
Source: Annual Congress 2008 - COPD
Year: 2008
Prognostic implications of delayed heart rate recovery from maximal-incremental exercise in patients with pulmonary arterial hypertension
Source: Annual Congress 2012 - Limiting factors in exercise
Year: 2012
Prognostic value of hemodynamics following treatment initiation in pulmonary arterial hypertension
Source: International Congress 2017 – Cardiac function assessment in pulmonary hypertension
Year: 2017
The prognostic role of the electrocardiogram in primary pulmonary hypertension
Source: Eur Respir J 2001; 18: Suppl. 33, 414s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept